Clinical
Cannabis … in wafer form?
Clinical trials of cannabis sublingual wafers begin this week after approval by the TGA A clinical trial of a unique ‘cannabis wafer product’ has been approved by the TGA, with …
A nudge in the right direction
Lowering the default amount of opioid pills in EMRs may reduce prescribing in midst of an opioid crisis, new study finds A new study published in JAMA Surgery has found …
Understanding insulin pumps
With a new choice on the market, we look into what pharmacists need to know about insulin pumps for patients with diabetes Since 1 July 2016, government-subsidised National Diabetes Services …
Strong genetic link to hayfever confirmed
Australian scientists have helped to uncover 41 genetic regions, which are estimated to account for about 40% of the genetic risk of hayfever A large international study, including contributions from …
Easing the load
A study of more than 131,000 patients has found pharmacists were able to alleviate GP workload by following up new hypertensive prescriptions In the UK, the New Medicine Service (NMS) …
Look out for the warning signs
TGA reminds health professionals to communicate the potential risks of medicines associated with neuropsychiatric adverse events The TGA has issued a reminder to health professionals on communicating the potential risks …
Cannabis and pain: it’s complicated
A new study of 1500 participants, recruited through Australian community pharmacies, has found cannabis may not necessarily be a panacea for pain Cannabis has been heralded as a potential alternative …
Pleasure on the brain
In the mid-1600s, not long after Shakespeare’s time, there was a drug that captured headlines just as ice does today It wove its dark web through Western society. So damaging …
E-medication management not a ‘panacea’: study
Organisations must remain vigilant to the risk of new errors following the roll-out of eMM systems, say Melbourne medication safety pharmacists While electronic medication management systems (eMMS) have been demonstrated …
Positive impacts on a range of health factors
New research reveals community pharmacist-led interventions can positively impact on medication adherence, BP control, cholesterol management, COPD and asthma control Researchers from the School of Pharmacy at The University of …
Reviewing the evidence
AJP looks closely at some of the statements in the recent JPPR debate between GP Dr Evan Ackermann and consultant clinical pharmacist Debbie Rigby This week we covered a new …
Script issues
Study reveals disproportionately high rates of oxycodone prescribing in a rural area New Australian research has revealed concerning levels of oxycodone in western Victoria, with experts calling for investigation on …